Researchers Submit Patent Application, "Composition For Treating Damaged Epithelial Surfaces And Method Of Producing Same", for Approval (USPTO 20240358752).

Researchers have submitted a patent application for a composition aimed at treating damaged epithelial surfaces, particularly in the context of eye diseases. The invention focuses on utilizing blood fractions obtained through ultracentrifugation of serum or plasma, which are free of lipids and lipoproteins, to promote wound healing and reduce inflammation in corneal epithelial cells. This method offers a potential solution for treating conditions like dry eyes without the need for autologous blood donation, addressing regulatory challenges associated with blood-derived products. [Extracted from the article]